Pacing and clinical electrophysiology : PACE · 2026
Dual-Chamber Leadless Pacemaker Implants in the Young.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Mamidi Akshitha, Cortez Daniel
Аннотация
INTRODUCTION: Young populations with traditional dual-chamber pacemakers are prone to re-intervention compared to their adult populations due to their active lifestyle. AVEIR DR Dual-Chamber Leadless Pacemakers are a new and less invasive approach to traditional pacemakers. Currently, few reports exist to support dual-chamber leadless pacemaker implants in the young.
METHODS: AVEIR DR dual-chamber leadless pacemakers were implanted in young patients (< 21 years old), at UC Davis Medical Center. Internal jugular vein was the preferred approach for most patients during implantation; however, one patient had a femoral approach after lead extraction.
RESULTS: Five patients received the AVEIR DR dual-chamber leadless pacemaker with a median age of 15 years, and a median weight of 65.8 kg. Access from the internal jugular vein was used in four out of five patients. Median predicted atrial longevity and ventricular longevity were 11.8 and 14.6 years, respectively. Atrial and ventricular impedance, threshold, and pacing were monitored with no complications with a median follow-up of 13 months.
CONCLUSION: Dual-chamber leadless pacemaker implants are feasible in young patients through femoral and internal jugular vein access.
METHODS: AVEIR DR dual-chamber leadless pacemakers were implanted in young patients (< 21 years old), at UC Davis Medical Center. Internal jugular vein was the preferred approach for most patients during implantation; however, one patient had a femoral approach after lead extraction.
RESULTS: Five patients received the AVEIR DR dual-chamber leadless pacemaker with a median age of 15 years, and a median weight of 65.8 kg. Access from the internal jugular vein was used in four out of five patients. Median predicted atrial longevity and ventricular longevity were 11.8 and 14.6 years, respectively. Atrial and ventricular impedance, threshold, and pacing were monitored with no complications with a median follow-up of 13 months.
CONCLUSION: Dual-chamber leadless pacemaker implants are feasible in young patients through femoral and internal jugular vein access.